skip to main content

Methadone Dose Increase Assessment — MRCPsych Paper B MCQ

Instant feedback + full explanation. One question, done properly.

HardSubstance MisuseMethadone Dose Increase AssessmentMRCPsych Paper B

At a planned prescribing review, a patient who has received methadone 80 mg once daily for four weeks requests an increase to 100 mg. He reports using heroin most evenings, particularly when he feels the methadone effect is wearing off. No further clinical assessment has yet been undertaken. Which is the most appropriate approach before deciding whether to increase the dose?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EReview adherence and dose timing, withdrawal or intoxication, other opioid and sedative use, and overdose risk; use toxicology selectively if it would inform management.

Explanation lettering: C = shown as A · D = shown as B · E = shown as C · A = shown as D · B = shown as E

B is correct. Current DHSC guidance requires assessment before every incremental change in opioid-substitution-treatment dose. The review should establish adherence and tolerance, response across the dosing interval, withdrawal or intoxication, the pattern of heroin use, concurrent alcohol, benzodiazepines or other sedatives, interactions and overdose risk. Continued heroin use at 80 mg may reflect underdosing, but it does not justify an automatic increase or a dose reduction. Toxicology can corroborate adherence or clarify uncertainty, but it does not establish dependence or tolerance and need not merely confirm use that the patient has disclosed. An ECG may be required earlier when QT-risk factors are present; without such factors, the SmPC recommends ECG monitoring before titration above 100 mg/day, not automatically when increasing to exactly 100 mg/day.

Reference: Department of Health and Social Care. Oral methadone and buprenorphine: recommendations, sections “Prescribing the optimal dose” and “Appropriate monitoring of the patient”. 2024. https://www.gov.uk/government/publications/medicine-choices-in-opioid-substitution-treatment/oral-methadone-and-buprenorphine-recommendations